Wed, Aug 27, 2014, 1:57 PM EDT - U.S. Markets close in 2 hrs 3 mins

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • insm_truth_teller insm_truth_teller Feb 28, 2013 8:08 AM Flag

    Fraud exposed Latent TB and Arikace

    Again...sheer nonsense from fud. Latent TB is not treated. It is like saying, "I have a latent headache, I'll take an aspirin." It doesn't work that way. Arikace is not prophylactic therapy.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Again...sheer nonsense from fud. Latent TB is not treated. It is like saying, "I have a latent headache, I'll take an aspirin." It doesn't work that way. Arikace is not prophylactic therapy.

    • Latent TB is treated variously with one or two oral anti-TB drugs for 9 months. Read CDC or WHO. But the treatments are to prevent the TB from becoming clinically active in the infected person. Latent TB patients are tuberculin skin test positive, but not aerosolizing TB bacteria. But they treat (isoniazid alone for 9 months in the US) keep any replicating bacteria suppressed. What fud is saying is that amikacin would be elevated to a first line TB antibiotic from its current position of a second line antibiotic because of inhalational administration. They only use amikacin now if they think the TB will break-out of the lungs and go to internal organs. One of the most painful disease in the world is TB of the bone marrow. Fortunately it is rare. No one wants that.type of disease.

      I have been doing a lot of research and I think INSMs should complete the masterfile for the liposome very quickly and take a serious look at inhaled vaccinations. Lots of viruses enter the body through the lungs and the lungs have their own immune system based on the fixed macrophages of the conducting airways and the alveoli. You heard it here first. Let's see the Spumpers plagarize that one.

      Sentiment: Strong Buy

 
INSM
13.92-0.120(-0.85%)1:56 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.